Role of bone marrow-derived cells in tumor angiogenesis and treatment
Open Access
- 1 June 2003
- journal article
- preview
- Published by Elsevier in Cancer Cell
- Vol. 3 (6) , 515-516
- https://doi.org/10.1016/s1535-6108(03)00138-7
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Tumor Response to Radiotherapy Regulated by Endothelial Cell ApoptosisScience, 2003
- Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cellsNature Medicine, 2003
- Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1+ stem cells from bone-marrow microenvironmentNature Medicine, 2002
- RETRACTED ARTICLE: Pluripotency of mesenchymal stem cells derived from adult marrowNature, 2002
- Dissecting tumour pathophysiology using intravital microscopyNature Reviews Cancer, 2002
- Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growthNature Medicine, 2001
- Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditionsNature Medicine, 2001
- Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferonNature Medicine, 1999
- Isolation of Putative Progenitor Endothelial Cells for AngiogenesisScience, 1997
- During angiogenesis, vascular endothelial growth factor regulate natural killer cell adhesion to tumor endotheliumNature Medicine, 1996